News Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program Continue Reading Previous Arbutus Presents New Data on AB-729, AB-836 and AB-101 at the EASL International Liver Congress™ 2022 and Provides AB-836 Clinical UpdateNext Madrigal Pharmaceuticals Presents Late-Breaking Phase 3 NASH Data and Multiple Oral Abstracts at EASL’s International Liver Congress™ Related Stories News Four-Person Dutch Startup Launches Europe’s First Sovereign AI Platform – Beyond the Reach of US Cloud Law News naoo AG Launches METIS: Real-Time Experimentation Infrastructure Completes Proprietary AI Stack News Zoonova AI Launches Alpha AI, Bringing Quant-Driven Analytics to Everyday Investors News Netic and OVHcloud Forge Strategic Partnership to Bolster Digital Sovereignty for Danish Enterprises, Public & Highly Regulated Sectors News Avantor India Expands its Strategic Collaboration with Parafilm to Serve the Indian Laboratory Consumables Market News Avantor India Expands its Strategic Collaboration with Parafilm to Serve the Indian Laboratory Consumables Market
